ClinicalTrials.gg
Not yet recruitingNCT07867613Updated Oct 9, 2026

The Effect of White Noise on Sleep, Quality of Recovery, and Satisfaction in Patients Undergoing Laparoscopic Cholecystectomy

An interventional study of White Noise in Laparoscopic Cholecystectomy, sponsored by Ataturk University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Ataturk University · Not applicable, Interventional, and Supportive care

Updated Oct 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized controlled trial aims to evaluate the effect of white noise on sleep, recovery quality, and satisfaction in patients undergoing laparoscopic cholecystectomy. In the postoperative period, patients encounter numerous physical and psychological stressors, such as pain, difficulty adapting to the hospital environment, immobilization, environmental noise, frequent nursing interventions, individual characteristics, and illness-related anxieties. These factors disrupt sleep patterns; a decline in sleep quality can negatively affect tissue healing, immune function, pain control, psychological well-being, and the overall recovery process. Consequently, patient satisfaction with the care process may also decrease. Although pharmacological methods are commonly used to manage postoperative insomnia, they are not always sufficiently effective and carry various limitations, such as sedation, drug interactions, and other adverse effects. Therefore, interest has grown in recent years regarding non-pharmacological interventions that are safe, cost-effective, easy to implement, and carry a low risk of side effects. White noise, one such intervention, can create a more favorable sleep environment by masking irregular environmental sounds, promote relaxation, and has the potential to improve sleep quality.

Read the detailed description

Studies indicate that patients must cope with issues such as pain, anxiety, and environmental noise during the postoperative period following surgical interventions. These factors negatively affect patients' sleep, quality of recovery, and satisfaction with care. Although laparoscopic cholecystectomy involves a short hospital stay, sleep problems are frequently observed during the first 24 hours postoperatively due to factors such as shoulder and abdominal pain, nausea, and ward noise. While pharmacological pain control and sleep-regulating agents are used to alleviate insomnia, they are not fully effective on their own due to potential side effects such as respiratory depression, delirium, and nausea/vomiting; therefore, it is recommended that pharmacological approaches be supplemented with non-pharmacological interventions. Recent studies demonstrate a growing interest in non-pharmacological methods within postoperative care.

Non-pharmacological methods include practices such as taking a warm shower, optimizing the environment for sleep, massage, listening to music, and aromatherapy. One such method is the use of white noise. White noise is a non-pharmacological intervention that creates a more suitable and uninterrupted sleep environment by masking irregular environmental sounds. By providing constant acoustic stimulation, it reduces the perception of environmental noise, facilitates the transition to sleep, supports sleep quality, and can help reduce nighttime awakenings. The literature indicates that white noise suppresses the stress response by increasing parasympathetic activity and contributes to the quality of recovery and patient satisfaction by lowering pain thresholds and anxiety levels. Studies in the literature demonstrate the positive effects of white noise on sleep quality and patient experience across various patient groups. Cho and Hwang (2021) reported that white noise application improved sleep quality in hospitalized patients. Similarly, a 2016 study conducted with individuals aged 65 and older in a coronary intensive care unit found that white noise enhanced sleep quality and patient satisfaction. Positive effects of white noise have also been observed in surgical patient groups. Dai et al. (2026) reported beneficial effects of white noise on sleep in patients following ureteroscopic lithotripsy. Furthermore, a study involving intensive care patients determined that white noise contributed to improvements in sleep duration and sleep efficiency. In a study of patients undergoing lumbar disc herniation surgery, Kızılkaya et al. (2026) noted that white noise increased levels of sleep quality, comfort, and satisfaction. Another study reported that white noise administered during arthroscopic surgery increased patient satisfaction and comfort levels, while also resulting in significant increases in respiratory rate and oxygen saturation, and significant decreases in heart rate and systolic and diastolic blood pressure. Oshvandi et al. (2020) reported that the application of white noise-consisting of sounds such as ocean waves, rivers, and rain-reduced sleep disturbances and increased patient comfort in patients monitored in the intensive care unit following open-heart surgery.

These findings indicate that white noise is a safe and feasible method capable of supporting sleep quality, enhancing patient comfort, and contributing to satisfaction with care across various clinical settings. A review of the literature reveals that while most studies on white noise application have focused on newborns and intensive care patients, research regarding its use in the postoperative period remains limited. In particular, the scarcity of studies simultaneously evaluating the effects of white noise on sleep quality, recovery quality, and patient satisfaction-specifically in patients undergoing laparoscopic cholecystectomy-underscores the necessity of this research.

In this context, it is anticipated that the application of white noise could serve as an effective, innovative, and easily implementable nursing intervention to improve sleep and recovery quality among surgical patients. Although the literature contains numerous studies on the use of white noise in neonatal intensive care units and with pediatric patients, there is a notable gap regarding its application as a specific intervention for surgical patient populations. By addressing this gap, the proposed randomized controlled trial will contribute to the development of evidence-based, non-pharmacological nursing practices applicable during the postoperative period. The findings are expected to provide a scientific basis for clinical practices aimed at enhancing patient safety and sleep quality, as well as improving the overall quality of care.

02

Conditions studied

  • Laparoscopic Cholecystectomy

Keywords

  • White Noise
  • Sleep Quality
  • Quality of Recovery
  • Patient Satisfaction
  • Laparoscopic Cholecystectomy
03

In context

Sleep Initiation and Maintenance Disorders

1,925 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 612 are open to participants now.

This study's planned enrollment of 64 is below the median of 72 across 1,689 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Ataturk University is the lead sponsor of 454 studies on the registry; 123 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 18 years of age or older,Undergoing laparoscopic cholecystectomy,
  • Being conscious, oriented, and cooperative,
  • Having no hearing impairment,
  • Having no condition that would prevent listening to white noise,
  • Having no physical condition that would prevent the use of a smartwatch,
  • Being in a stable general condition,
  • Volunteering to participate in the study.
  • Having no diagnosed psychiatric, neurological, or cognitive disorder.
  • Having no diagnosed sleep disorder and not regularly using sleep medication

Exclusion criteria

Exclusion Criteria:

  • Conversion from laparoscopic surgery to open surgery,
  • Developing a serious postoperative complication,
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • No intervention
    Control Group

    Participants will receive routine postoperative care without white noise

  • Experimental
    White Noise

    Participants will receive white noise in addition to routine postoperative care

    Other: White Noise

Interventions

  • OtherWhite Noise

    Patients in the white noise group will receive white noise in addition to routine nursing care. The intervention will be administered in the patient's room in a manner that does not disturb them. Patients will listen to white noise (sounds of rain and waterfalls) via Bluetooth headphones for 30 minutes before bedtime on the evening of postoperative days 0 and 1. Following the white noise intervention, sleep monitoring will be initiated using a smartwatch worn by the patient. Data obtained from the smartwatch will be recorded on the mornings of postoperative days 1 and 2. Subsequently, the Richard-Campbell Sleep Questionnaire and the Quality of Recovery Scale will be completed on the mornings of postoperative days 1 and 2, following morning treatment. A satisfaction scale will be administered on postoperative day 2 to assess the level of satisfaction with the intervention.

06

What researchers measure

Primary outcomes

  1. Richard-Campbell Sleep Questionnaire

    The scale was developed by Richards in 1987. Its validity and reliability in Turkey were established by Özlü and Özer in 2015. The RCUÖ assesses the depth of nighttime sleep, sleep onset latency, frequency of awakenings, duration of wakefulness after waking, sleep quality, and environmental noise levels. It consists of a total of six items. Each item is evaluated using a visual analog scale ranging from 0 to 100. A score of 0-25 indicates "very poor sleep," while a score of 76-100 indicates "very good sleep." As the scale score increases, the patients' sleep quality improves.

    Time frame: Postoperative days 1 and 2

  2. Quality of Recovery Scale-15

    The Turkish validity and reliability study of the scale developed by Stark et al. (2013) was conducted by Kara et al. (2022). A visual analog scale is used within the quality of recovery scale to assess general well-being. The scale consists of 15 items and two sub-dimensions; for each item, the visual analog scale comprises a horizontal line 10 cm in length. Each centimeter represents 1 point, and the score range for each item is 0-10. Scoring is defined as 0 = "never" to 10 = "always" for positive items, and 0 = "always" to 10 = "never" for negative items; the total score range for the scale is 0-150. Higher scores indicate better quality of recovery.

    Time frame: Postoperative days 1 and 2

  3. VAS-Patient Satisfaction Scale:

    This will be used to determine patients' levels of satisfaction with the care process and the procedure. The scale consists of a 10 cm horizontal line, with the phrase "Not at all satisfied" at one end and "Very satisfied" at the other. The patient will mark their level of satisfaction regarding the care process on the line. The marked point will indicate the patient's satisfaction score, with a higher score signifying a higher level of satisfaction.

    Time frame: Postoperative days 2

Secondary outcomes

  1. Total Sleep Duration Measured by [Smartwatch Brand and Model]

    Total sleep duration will be assessed using the \[full brand and model name of the smartwatch\]. Total sleep duration will be recorded in minutes, representing the total amount of sleep detected by the device during the nighttime sleep period.

    Time frame: Postoperative days 1 and 2

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Aug 2027, 10 months later.

Of 825 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 41. This study's planned 10 months is below that.

Counting every sponsor, half of 883 studies reached it within 19 months; a quarter within 7 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 18, 2026
First posted
Oct 9, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Aug 1, 2027
CompletionEst.
Aug 1, 2027
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07867613
Lead sponsor
Ataturk University
Responsible party
Tülay KILINÇ (Assistant Professor, Ataturk University) — Principal investigator
First posted
Oct 9, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Aug 1, 2027 (estimated)
Completion
Aug 1, 2027 (estimated)
Last update
Oct 9, 2026

Study contacts

Tülay KILINÇ, PhD
Contact
tlyhmsre@hotmail.com
05376592051
Tülay KILINÇ, PhD
Contact
ayseguul21@hotmail.com
05376592051
TÜLAY KILINÇ, PhD
principal investigator · Ataturk University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion